bioAffinity Technologies and UT Health Science Center Collaborate to Optimize Cancer Diagnostics and Therapeutics
July 13, 2016 08:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 13, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the renewal of its collaborative agreement with The University of Texas Health Science Center at San Antonio...
bioAffinity Technologies Appoints New Senior VP for Research & Development of Therapeutics
July 07, 2016 08:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 07, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced that William Bauta, Ph.D., will join the company in September 2016 as Senior Vice President for Research and...
bioAffinity Technologies Forms Subsidiary to Focus on Targeted Cancer Drug Delivery
June 23, 2016 08:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, June 23, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s...
bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference
April 12, 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...
bioAffinity Technologies Appoints New Science Team
April 04, 2016 09:19 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, April 04, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that Vivienne Rebel, M.D., Ph.D., has joined the Company as...